| Symbol | NAGE |
|---|---|
| Name | NIAGEN BIOSCIENCE, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | 10900 WILSHIRE BLVD.,SUITE 600, LOS ANGELES, California, 90024, United States |
| Telephone | +1 -310 388-6706 |
| Fax | — |
| — | |
| Website | https://www.niagenbioscience.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001386570 |
| Description | Niagen is one of the most advanced, scientifically researched NAD precursors, proven to restore what aging takes away. Backed by 35 clinical studies, protected by global patents, and trusted by leading researchers, it is the foundation of cellular vitality and optimal healthspan. Additional info from NASDAQ: |
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
Read moreNiagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
Read moreNiagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence
Read moreNiagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
Read moreNiagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Read moreLopez Carlos Luis 🟢 acquired 2.3K shares of Niagen Bioscience, Inc. (NAGE) at $2.71 Transaction Date: Jun 30, 2026 | Filing ID: 000001
Read morePamir Ozan 🟢 acquired 4.3K shares of Niagen Bioscience, Inc. (NAGE) at $2.71 Transaction Date: Jun 30, 2026 | Filing ID: 000001
Read moreDirector Fried Robert N 🟢 acquired 1.1K shares of Niagen Bioscience, Inc. (NAGE) at $2.71 Transaction Date: Jun 30, 2026 | Filing ID: 000002
Read more